当前位置:首页 - 行情中心 - 中国医药(600056) - 财务分析 - 现金流量表

中国医药

(600056)

  

流通市值:134.58亿  总市值:134.63亿
流通股本:14.95亿   总股本:14.96亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金16,244,973,944.627,119,853,796.2236,675,363,987.4625,296,007,858.12
  收到的税费返还93,147,959.481,671,584.6194,162,850.64102,830,821.29
  收到其他与经营活动有关的现金522,106,993.41168,046,218.53635,740,003.15878,121,718.02
  经营活动现金流入小计16,860,228,897.437,369,571,599.3637,405,266,841.2526,276,960,397.43
  购买商品、接受劳务支付的现金15,294,354,203.337,567,697,809.1732,003,303,859.7323,365,781,925.53
  支付给职工以及为职工支付的现金917,109,715.58497,502,931.581,498,072,594.871,139,571,802.91
  支付的各项税费594,648,864.92276,234,808.79920,585,670.27797,251,952.33
  支付其他与经营活动有关的现金916,869,001.18449,456,149.111,557,425,437.361,286,892,517.67
  经营活动现金流出小计17,722,981,785.018,790,891,698.6535,979,387,562.2326,589,498,198.44
  经营活动产生的现金流量净额-862,752,887.58-1,421,320,099.291,425,879,279.02-312,537,801.01
二、投资活动产生的现金流量:
  收回投资收到的现金4,190,5604,190,5604,217,394.56-
  取得投资收益收到的现金10,800,00010,800,000--
  处置固定资产、无形资产和其他长期资产收回的现金净额3,647,736396,40625,120,404.9918,078,258.76
  处置子公司及其他营业单位收到的现金净额1---
  收到的其他与投资活动有关的现金--11,011,563.639,862,663.63
  投资活动现金流入小计18,638,29715,386,96640,349,363.1827,940,922.39
  购建固定资产、无形资产和其他长期资产支付的现金112,411,761.3656,795,571.9333,113,437.85209,638,249.8
  投资支付的现金-354,157,017.93--
  取得子公司及其他营业单位支付的现金331,175,579.78-4,134,7394,134,739
  支付其他与投资活动有关的现金--2,708,467.57-
  投资活动现金流出小计443,587,341.14410,952,589.83339,956,644.42213,772,988.8
  投资活动产生的现金流量净额-424,949,044.14-395,565,623.83-299,607,281.24-185,832,066.41
三、筹资活动产生的现金流量:
  吸收投资收到的现金--40,000,00020,000,000
  其中:子公司吸收少数股东投资收到的现金--40,000,00020,000,000
  取得借款收到的现金3,443,300,840.041,254,993,949.956,445,869,018.493,401,822,921.35
  收到其他与筹资活动有关的现金200,000200,00018,461,057.975,681,057.97
  筹资活动现金流入小计3,443,500,840.041,255,193,949.956,504,330,076.463,427,503,979.32
  偿还债务支付的现金1,986,138,414.351,084,493,085.126,571,268,815.493,326,919,569.32
  分配股利、利润或偿付利息支付的现金284,560,110.4328,772,180.42501,930,310.49445,346,955.58
  其中:子公司支付给少数股东的股利、利润187,542,125.2-198,416,185.45162,165,661.76
  支付其他与筹资活动有关的现金399,522,616.0760,743,127.191,035,444,092.97771,047,278.82
  筹资活动现金流出小计2,670,221,140.851,174,008,392.738,108,643,218.954,543,313,803.72
  筹资活动产生的现金流量净额773,279,699.1981,185,557.22-1,604,313,142.49-1,115,809,824.4
四、汇率变动对现金及现金等价物的影响-2,259,883.42-110,384.4-12,441,591-4,976,557.26
五、现金及现金等价物净增加额-516,682,115.95-1,735,810,550.3-490,482,735.71-1,619,156,249.08
  加:期初现金及现金等价物余额3,349,885,707.673,349,885,707.673,840,368,443.383,857,149,690.47
  期末现金及现金等价物余额2,833,203,591.721,614,075,157.373,349,885,707.672,237,993,441.39
补充资料:
  净利润312,220,347.57-674,635,843.84-
  资产减值准备3,912,657.81-150,703,551.68-
  固定资产和投资性房地产折旧125,110,703.81-252,381,359.62-
  无形资产摊销60,976,665.97-101,436,444.07-
  长期待摊费用摊销38,056,229.97-56,996,546.05-
  处置固定资产、无形资产和其他长期资产的损失-3,105,152.69--18,303,039.78-
  固定资产报废损失894,782.48-1,598,196.22-
  公允价值变动损失--2,210,527.65-
  财务费用134,335,725.63-131,368,420.18-
  投资损失-34,006,358.92--17,942,288.17-
  递延所得税20,425,860.22--27,778,620.47-
  其中:递延所得税资产减少-22,558,596.82-13,212,105.06-
    递延所得税负债增加42,984,457.04--40,990,725.53-
  存货的减少-76,955,141.11-190,480,458.3-
  经营性应收项目的减少-1,763,641,396.41--1,267,153,121.41-
  经营性应付项目的增加122,060,740.11-980,638,899.24-
  不涉及现金收支的投资和筹资活动金额其他项目--62,405,672.33-
  现金的期末余额2,833,203,591.72-3,349,885,707.67-
  减:现金的期初余额3,349,885,707.67-3,840,368,443.38-
  现金及现金等价物的净增加额-516,682,115.95--490,482,735.71-
公告日期2026-08-262026-04-292026-04-252025-10-28
审计意见(境内)标准无保留意见
TOP↑